|
|
|
Years after being treated for Rhabdomyosarcoma, Abby joins a research studyMore than a decade after Abby’s cancer treatment, she and her family joined a COG research study aiming to better understand the rare soft tissue cancer she had. Learn why all these years later, one of her oncologists at Cincinnati Children’s is still inspired by her perseverance and positivity.
|
|
Jeffrey’s Legacy Becomes Larger Than LeukemiaThe Jeffrey Pride Foundation will soon mark 25 years of giving to pediatric cancer research. As they fundraise, they honor the life of their namesake with steadfast hope for more effective treatments. This year, one of several research projects they support is going global and aims to improve outcomes for children with the same rare type of leukemia their friend Jeffrey had.
|
|
JADE’S HOPE FOR A FUTURE WITH MORE EQUITABLE CAREAt 15, Jade Gibson was diagnosed with a rare germ-cell ovarian cancer. In the 19 years since her doctor at her hometown hospital in Georgia walked her through her treatment plan, Jade has been advocating for improved services for adolescent and young adult cancer patients in rural communities. Today, she also serves as a patient advocate for the Children's Oncology Group. |
|
A Young Football Player’s Legacy Helps Science Tackle OsteosarcomaSmart and athletic. Kind and creative. Mason Allen was a kid everyone adored. Five years after his passing, Mason’s legacy was a catalyst for Dr. John Doski’s research into game-changing knowledge in diagnosing, treating and operating on pediatric osteosarcoma patients – the same cancer Mason had.
|
|
How Brady Beat Cancer with Better TreatmentThree years after 14-year-old Brady learned he had cancer, he and his parents reflect on their family’s journey and the opportunity to join the Children’s Oncology Group’s effort to bring less toxic treatments to patients. This is Brady’s larotrectinib story.
|